Among all the 368 pairs of CRC patients, GLUT1 expression levels in CRC tumor tissues were significantly higher than those in the corresponding adjacent normal tissues (P<0.001), which indicates that GLUT1 contributes to the susceptibility of CRC. This evidence concerns the gene SLC2A1 and colorectal carcinoma.